HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: AHAs and photoaged skin

This article was originally published in The Rose Sheet

Executive Summary

AHAs and photoaged skin: Study published in the February issue of the Journal of the American Academy of Dermatology concludes that treatment with AHAs "produced significant reversal of epidermal and dermal markers of photoaging." The study, which tested the efficacy of 25% AHA lotion with a pH of 3.5 on photoaged skin in 17 white subjects, found that AHAs "caused an approximate 25% increase in skin thickness" and papillary dermal changes included "improved quality of elastic fibers and increased density of collagen." In addition, "no evidence of inflammation was evident" in the subjects. The participants applied the AHA lotion twice daily on one forearm for "an average of six months" (4-8 month range) while the other arm was treated with placebo. Five subjects were treated with lactic acid; five with glycolic acid; and seven with citric acid. The study was conducted by Cherie Ditre, MD, et al...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS002508

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel